Moderna noted the FDA did not identify any specific safety concerns with the vaccine and that the rejection was inconsistent with previous feedback.

Senior FDA official Vinay Prasad reportedly overrode his staff in deciding to reject Moderna's application for a new seasonal flu shot.

In a rare and surprising move, the FDA has issued a “Refusal to File” letter for Moderna’s mRNA-1010 influenza vaccine.

In this clip Kristian, Roxy and Mike discuss the new trailer for the Netflix series, One Piece Season 2. #clips #podcast ...

The FDA’s refuse-to-file letter cited no safety or efficacy concerns for Moderna’s influenza vaccine.

BATTLE LAKE, Minn. - In recent years, Republican lawmakers have often steered clear of talking to the mainstream media. That means that when I reach out to state legislators in greater Minnesota, who ...

Health news and commentary gathered by MedPage Today staff ...

A year of significant policy change at the FDA brought momentum and scrutiny into the new year. As 2026 gets underway, biopharma companies are responding to sweeping vaccine changes while concerns ...

The idea of self-amplifying gene editing is to get cells to pass on packages of CRISPR machinery to their neighbours, boosting the effect ...

Headlines are dominated by the oncoming AI apocalypse. The 21st century, far from being an age of decay, may prove to be the ...

A local bakery: Valentine’s Day is here, and in Highland Park, that means Delicias Bakery & Some is transforming from a family-owned panadería into an intimate evening restaurant for the weekend. This ...